IS5727A - Meðferðarsamsetningar af (valvísum) estrógen viðtakabeinum (SERM) og vaxtarhormónaseytum (GHS) til að meðhöndla veikleika beinagrindarvöðva - Google Patents

Meðferðarsamsetningar af (valvísum) estrógen viðtakabeinum (SERM) og vaxtarhormónaseytum (GHS) til að meðhöndla veikleika beinagrindarvöðva

Info

Publication number
IS5727A
IS5727A IS5727A IS5727A IS5727A IS 5727 A IS5727 A IS 5727A IS 5727 A IS5727 A IS 5727A IS 5727 A IS5727 A IS 5727A IS 5727 A IS5727 A IS 5727A
Authority
IS
Iceland
Prior art keywords
ghs
serm
selective
growth hormone
skeletal muscle
Prior art date
Application number
IS5727A
Other languages
English (en)
Icelandic (is)
Inventor
Zhu Ke Hua
Li Mei
Codetta Pan Lydia
Duane Thompson David
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of IS5727A publication Critical patent/IS5727A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
IS5727A 1998-06-16 2000-11-24 Meðferðarsamsetningar af (valvísum) estrógen viðtakabeinum (SERM) og vaxtarhormónaseytum (GHS) til að meðhöndla veikleika beinagrindarvöðva IS5727A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8942498P 1998-06-16 1998-06-16
PCT/IB1999/000796 WO1999065488A1 (en) 1998-06-16 1999-05-03 Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty

Publications (1)

Publication Number Publication Date
IS5727A true IS5727A (is) 2000-11-24

Family

ID=22217565

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5727A IS5727A (is) 1998-06-16 2000-11-24 Meðferðarsamsetningar af (valvísum) estrógen viðtakabeinum (SERM) og vaxtarhormónaseytum (GHS) til að meðhöndla veikleika beinagrindarvöðva

Country Status (29)

Country Link
EP (1) EP1085867A1 (ko)
JP (1) JP2002518328A (ko)
KR (1) KR20010052817A (ko)
CN (1) CN1305378A (ko)
AP (1) AP9901581A0 (ko)
AR (1) AR018868A1 (ko)
AU (1) AU3342099A (ko)
BG (1) BG105128A (ko)
BR (1) BR9911357A (ko)
CA (1) CA2335112A1 (ko)
CO (1) CO5070586A1 (ko)
EA (1) EA200001189A1 (ko)
GT (1) GT199900083A (ko)
HR (1) HRP20000857A2 (ko)
HU (1) HUP0102395A2 (ko)
ID (1) ID26726A (ko)
IL (1) IL139587A0 (ko)
IS (1) IS5727A (ko)
MA (1) MA26648A1 (ko)
NO (1) NO20006381L (ko)
OA (1) OA11569A (ko)
PA (1) PA8472101A1 (ko)
PE (1) PE20000633A1 (ko)
PL (1) PL345064A1 (ko)
SK (1) SK18902000A3 (ko)
TN (1) TNSN99118A1 (ko)
UY (1) UY25557A1 (ko)
WO (1) WO1999065488A1 (ko)
ZA (1) ZA993973B (ko)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1004306A3 (en) * 1998-08-06 2000-06-07 Pfizer Products Inc. Estrogen agonists/antagonists
JP2004507502A (ja) 2000-08-30 2004-03-11 ファイザー・プロダクツ・インク 成長ホルモン分泌促進物質のための徐放性製剤
IL145106A0 (en) * 2000-08-30 2002-06-30 Pfizer Prod Inc Intermittent administration of a geowth hormone secretagogue
US7524866B2 (en) 2001-11-29 2009-04-28 Gtx, Inc. Prevention and treatment of androgen—deprivation induced osteoporosis
EP1666033B1 (en) * 2001-11-29 2008-12-31 GTX, Inc. Prevention and treatment of androgen-deprivation induced osteoporosis
US7476653B2 (en) 2003-06-18 2009-01-13 Tranzyme Pharma, Inc. Macrocyclic modulators of the ghrelin receptor
CU23558A1 (es) 2006-02-28 2010-07-20 Ct Ingenieria Genetica Biotech Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento
JP2010518090A (ja) 2007-02-09 2010-05-27 トランザイム・ファーマ，インコーポレイテッド 大環状グレリン受容体修飾因子およびその使用方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA51676C2 (uk) * 1995-11-02 2002-12-16 Пфайзер Інк. (-)цис-6(s)-феніл-5(r)[4-(2-піролідин-1-ілетокси)феніл]-5,6,7,8-тетрагідронафталін-2-ол d-тартрат, спосіб його одержання, спосіб лікування захворювань, що піддаються лікуванню агоністами естрогену, та фармацевтична композиція
TW432073B (en) * 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
HN1996000101A (es) * 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis

Also Published As

Publication number Publication date
ID26726A (id) 2001-02-01
PL345064A1 (en) 2001-11-19
EP1085867A1 (en) 2001-03-28
TNSN99118A1 (fr) 2005-11-10
IL139587A0 (en) 2002-02-10
NO20006381D0 (no) 2000-12-14
GT199900083A (es) 2000-12-05
AU3342099A (en) 2000-01-05
WO1999065488A1 (en) 1999-12-23
SK18902000A3 (sk) 2001-12-03
CA2335112A1 (en) 1999-12-23
BG105128A (en) 2001-11-30
HUP0102395A2 (hu) 2001-11-28
EA200001189A1 (ru) 2001-06-25
MA26648A1 (fr) 2004-12-20
JP2002518328A (ja) 2002-06-25
AR018868A1 (es) 2001-12-12
KR20010052817A (ko) 2001-06-25
ZA993973B (en) 2000-12-15
CO5070586A1 (es) 2001-08-28
OA11569A (en) 2004-07-01
CN1305378A (zh) 2001-07-25
BR9911357A (pt) 2001-03-13
HRP20000857A2 (en) 2001-10-31
AP9901581A0 (en) 1999-06-30
PE20000633A1 (es) 2000-07-26
UY25557A1 (es) 2001-01-31
PA8472101A1 (es) 2000-09-29
NO20006381L (no) 2000-12-14

Similar Documents

Publication Publication Date Title
IS2595B (is) Prótínblanda og ferli til að einangra prótínblöndu úr vöðvavef
DK0946190T3 (da) Fremgangsmåder og sammensætninger til stimulering af neuritvækst
EP1143987A4 (en) NATURAL COMPOSITION AND METHOD FOR TREATING SEXUAL DYSFUNCTIONS
IS2390B (is) Aðferð við að fjarlægja vöðvakjöt af fiski og tæki til að framkvæma þá aðferð
EP1136141A4 (en) TREATMENT DEVICE, TREATMENT METHOD AND METHOD FOR TREATING FLOORS
EP1071841A4 (en) METHOD AND DEVICE FOR COUNTERFLOW TREATMENT OF SLUDGE
DK0898894T3 (da) Halvautomatisk indretning til udbening af griselår og fremgangsmåde til udbening af griselår under anvendelse af samme
IS5727A (is) Meðferðarsamsetningar af (valvísum) estrógen viðtakabeinum (SERM) og vaxtarhormónaseytum (GHS) til að meðhöndla veikleika beinagrindarvöðva
ZA984172B (en) Method of water treatment using zeolite crystalloid coagulants
IS4805A (is) Aðferð til meðhöndlunar og lyfjasamsetning
EP1166904A4 (en) METHOD FOR THE DETOXIFICATION OF FLOORS
DK3497A (da) Formulering med vedvarende frigivelse af et animalsk væksthormon og fremgangsmåde til fremstilling deraf
IS5691A (is) Meðferðarsamsetningar af (valvísum) estrógen viðtaka beinum (SERM) og vaxtarhormóns seytum (GHS) til meðhöndlunar á veikleika í beinagrindarvöðva
GB2333290B (en) Method of water treatment using zeolite crystalloid coagulants
NO20011824D0 (no) Gjödningsblandinger med kontrollert frigjöring og fremgangsmåter for fremstilling derav
AUPP010397A0 (en) Method and composition for treatment of sexual dysfunction
GB9913560D0 (en) Mixing apparatus and method of mixing
EP1296889A4 (en) PLASTICIZED MIXTURE AND METHOD OF USING THE MIXTURE
NO982112L (no) Blanding med bestemt dose, av en angiotensinkonverterende enzyminhibitor og en kalsiumkanal antagonist, fremgangsmÕte for fremstilling og anvendelse derav i behandling av kardiovaskulµre sykdommer
BR9508718A (pt) Estabelecimento e método para segregação de estrógeno tónico de ovário para regimes terapéuticos estendidos
NO20032969D0 (no) Fremgangsmåte for screening med hensyn på progesteronreseptorisoform-spesifikke ligander og med hensyn på vevs-selektiveprogesteronreseptorligander
EP1009433A4 (en) THERAPEUTIC COMPOSITION AND TREATMENT METHOD
DK1244662T3 (da) Pyridazinoquinolinderivater og fremgangsmåde til behandling af smerter
IS6428A (is) Aðferð og blanda til að meðhöndla sársauka
GB0010430D0 (en) Method and apparatus for non-manual installation of software,such as NT services